IdentificationGeneric Name(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamideDrugBank Accession NumberDB07861BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide (DB07861)× CloseWeightAverage: 420.481 Monoisotopic: 420.114377828 Chemical FormulaC23H20N2O4SSynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUUDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylaseNot AvailablePseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)AbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as 2-naphthalene sulfonic acids and derivatives. These are organic aromatic compounds that contain a naphthalene moiety that carries a sulfonic acid group (or a derivative thereof) at the 2-position. Naphthalene is a bicyclic compound that is made up of two fused benzene ring.KingdomOrganic compoundsSuper ClassBenzenoidsClassNaphthalenesSub ClassNaphthalene sulfonic acids and derivativesDirect Parent2-naphthalene sulfonic acids and derivativesAlternative Parents2-naphthalene sulfonamides / Alpha amino acids and derivatives / Organosulfonamides / Aminosulfonyl compounds / Hydroxamic acids / Organopnictogen compounds / Organonitrogen compounds / Organic oxides / Hydrocarbon derivatives / Carbonyl compoundsSubstituents2-naphthalene sulfonamide / 2-naphthalene sulfonic acid or derivatives / Alpha-amino acid or derivatives / Aminosulfonyl compound / Aromatic homopolycyclic compound / Carbonyl group / Carboxylic acid derivative / Hydrocarbon derivative / Hydroxamic acid / N-substituted-alpha-amino acidMolecular FrameworkAromatic homopolycyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyMMOUXLMPQFMDRD-JOCHJYFZSA-NInChIInChI=1S/C23H20N2O4S/c26-23(24-27)22(14-16-9-10-17-5-1-3-7-19(17)13-16)25-30(28,29)21-12-11-18-6-2-4-8-20(18)15-21/h1-13,15,22,25,27H,14H2,(H,24,26)/t22-/m1/s1IUPAC Name(2R)-N-hydroxy-3-(naphthalen-2-yl)-2-(naphthalene-2-sulfonamido)propanamideSMILES[H][C@](CC1=CC2=C(C=CC=C2)C=C1)(NS(=O)(=O)C1=CC2=C(C=CC=C2)C=C1)C(=O)NOReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound9823454PubChem Substance99444332ChemSpider7999201ChEMBLCHEMBL261713ZINCZINC000000594749PDBe LigandGVRPDB Entries2ves / 4isaClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.000431 mg/mLALOGPSlogP3.14ALOGPSlogP3.67ChemaxonlogS-6ALOGPSpKa (Strongest Acidic)8.69ChemaxonpKa (Strongest Basic)-5.5ChemaxonPhysiological Charge0ChemaxonHydrogen Acceptor Count4ChemaxonHydrogen Donor Count3ChemaxonPolar Surface Area95.5 Å2ChemaxonRotatable Bond Count5ChemaxonRefractivity114.8 m3·mol-1ChemaxonPolarizability43.4 Å3ChemaxonNumber of Rings4ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.8505Blood Brain Barrier+0.6629Caco-2 permeable-0.6419P-glycoprotein substrateNon-substrate0.5549P-glycoprotein inhibitor INon-inhibitor0.8916P-glycoprotein inhibitor IINon-inhibitor0.8709Renal organic cation transporterNon-inhibitor0.9359CYP450 2C9 substrateNon-substrate0.5908CYP450 2D6 substrateNon-substrate0.826CYP450 3A4 substrateNon-substrate0.6417CYP450 1A2 substrateNon-inhibitor0.7707CYP450 2C9 inhibitorNon-inhibitor0.711CYP450 2D6 inhibitorNon-inhibitor0.8779CYP450 2C19 inhibitorNon-inhibitor0.6661CYP450 3A4 inhibitorNon-inhibitor0.8251CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.7963Ames testNon AMES toxic0.6056CarcinogenicityNon-carcinogens0.7352BiodegradationNot ready biodegradable0.9965Rat acute toxicity2.3532 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9931hERG inhibition (predictor II)Non-inhibitor0.8742  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylaseKindProteinOrganismPseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)Pharmacological actionUnknownGeneral FunctionUdp-3-o-[3-hydroxymyristoyl] n-acetylglucosamine deacetylase activitySpecific FunctionInvolved in the biosynthesis of lipid A, a phosphorylated glycolipid that anchors the lipopolysaccharide to the outer membrane of the cell.Gene NamelpxCUniprot IDP47205Uniprot NameUDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylaseMolecular Weight33434.81 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:26 / Updated at June 12, 2020 16:52 